GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common StockGlobeNewsWire • 04/13/23
GLUCOTRACK TO BEGIN RESEARCH & DEVELOPMENT OF NOVEL CONTINUOUS GLUCOSE MONITORING SYSTEMGlobeNewsWire • 10/10/22
GlucoTrack, Inc. Provides Development Update on its Gen 2 Non-Invasive Glucose MonitorGlobeNewsWire • 06/22/22
GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol ChangeGlobeNewsWire • 03/14/22